Open AccessSynthesis and Imaging Validation of [18F]MDL100907 Enabled by Ni-Mediated Fluorination
Author(s) -
Hongliang Ren,
Hsiao Ying Wey,
Martin G. Strebl,
Ramesh Neelamegam,
Tobias Ritter,
Jacob M. Hooker
Publication year - 2014
Publication title -
acs chemical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.158
H-Index - 69
ISSN - 1948-7193
DOI - 10.1021/cn500078e
Subject(s) - 5 ht2a receptor , 5 ht receptor , pet imaging , positron emission tomography , nonhuman primate , serotonin , neuroscience , chemistry , nuclear medicine , psychology , receptor , medicine , biology , biochemistry , evolutionary biology
Several voids exist in reliable positron emission tomography (PET) radioligands for quantification of the serotonin (5HT) receptor system. Even in cases where 5HT radiotracers exist, challenges remain that have limited the utility of 5HT imaging in clinical research. Herein we address an unmet need in 5HT2a imaging using innovative chemistry. We report a scalable and robust synthesis of [(18)F]MDL100907, which was enabled by a Ni-mediated oxidative fluorination using [(18)F]fluoride. This first demonstration of a Ni-mediated fluorination used for PET imaging required development of a new reaction strategy that ultimately provided high specific activity [(18)F]MDL100907. Using the new synthetic strategy and optimized procedure, [(18)F]MDL100907 was evaluated against [(11)C]MDL100907 for reliability to quantify 5HT₂a in the nonhuman primate brain and was found to be superior based on a single scan analysis using the same nonhuman primate. The use of this new 5HT₂a radiotracer will afford clinical neuroscience research the ability to distinguish 5HT₂a receptor abnormalities binding between healthy subjects and patients even when group differences are small.